- Circ.Res. 101(3):268-276 (2007)
- Curr.Opin.Cell Biol. 19(2):117-123 (2007)
- Exp.Cell Res. 312(5):549-560 (2006)
- Genes Dev. 20(24):3347-3365 (2006)
- Trends Cell Biol. 16(6):293-300 (2006)
- J Biochem.Mol.Biol. 39(5):469-478 (2006)
- Nat.Rev.Cancer 7(6):475-485 (2007)
- Cancer Res. 69(6):2607-2614 (2009)
- Exp.Biol.Med.Maywood. 234(12):1417-1424 (2009)
- Cancer Res. 68(2):521-529 (2008)
- The molecular basis of class side effects due to treatment with inhibitors of the VEGF/VEGFR pathwayCurr.Clin.Pharmacol. 3(2):132-143 (2008)
- Nature 454(7204):656-660 (2008)
- VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signalingCirc.Res. 103(9):916-918 (2008)
- N.Engl.J.Med. 358(19):2039-2049 (2008)
- J.Vasc.Res. 45(3):259-268 (2008)
- J.Biol.Chem. 274(46):33057-33063 (1999)
- Science 282(5390):946-949 (1998)
- Angiogenesis. 3(1):33-39 (1999)
- Nat.Genet. 25(2):153-159 (2000)
- Oncologist. (2000)


user